Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: A systematic review with meta-analyses.
To compare the effectiveness, safety and acceptability of 1) in-clinic and remote/self-assessment and 2) different remote/self-assessments, for confirming the success of medical abortion at ≤10+0 weeks' gestation. Ovid Embase Classic and Embase; Ovid MEDLINE(R) and Epub Ahead-of-Print, In-Process & Other Non-Indexed Citations and Daily; and the Cochrane Library (19th November 2018). We also consulted experts in this field for any ongoing or missed trials. Randomized controlled trials (RCTs), published in English from 2000 onwards, comparing in-clinic assessment with ultrasound to remote or self-assessment or comparing different remote or self-assessment strategies to confirm the success of medical abortion of pregnancies up to and including 10+0 weeks gestation, reporting any of the following outcomes: 'missed ongoing pregnancy', 'correct implementation of the follow-up strategy', patient satisfaction/preference, 'adherence to follow-up strategy', 'unscheduled visits/telephone calls to the abortion service', and surgical intervention. One author assessed the risk of bias in the studies using the Cochrane Collaboration checklist for RCTs. All outcomes were analysed as risk ratios and meta-analysed in Review Manager 5.3 using the Mantel-Haenszel statistical method and a fixed effect model. The overall quality of the evidence was assessed using GRADE. Four RCTs (n=5,761) compared in-clinic to remote self-assessment and found no clinically significant differences apart from higher preference rates for remote follow-up, especially in the remote follow-up groups. The quality of this evidence was compromised by attrition, no blinding, inconsistency, indirectness, and low event rates. Two RCTs (n=1,125) compared different remote assessment strategies (using urine pregnancy tests) and also found no clinically significant differences apart from a clinically significantly lower rate of unscheduled visits to the abortion service in the remote follow-up group using a multi-level urine pregnancy test compared to remote follow-up using a high sensitivity urine pregnancy test. The quality of this evidence was compromised by small event rates, lack of blinding and indirectness and high attrition rates. The published data support offering women who have had a medical abortion up to and including 10+0 weeks' gestation, the choice of self-assessment, remote assessment, or clinic follow-up.